Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» biosimilars
biosimilars
Key Humira patent goes down via IPR—but biosims makers shouldn't celebrate yet, analysts warn
Fierce Pharma
Thu, 05/18/17 - 12:09 am
Humira
patents
AbbVie
biosimilars
Novartis pushes further into pain with Durect deal
BioPharma Dive
Tue, 05/9/17 - 10:45 pm
Novartis
Durect
Sandoz
biosimilars
generics
Posimir
R&D
Amid sales growth, Roche plans defense from biosimilar threats
BioPharma Dive
Fri, 04/28/17 - 10:30 am
Roche
biosimilars
Rituxan
Herceptin
Avastin
U.S. top court grapples over making copycat biologics available sooner
Yahoo/Reuters
Wed, 04/26/17 - 09:39 pm
biosimilars
Neupogen
Amgen
Supreme Court
Second biosimilar of Remicade approved in the US, but J&J not rattled
BioPharma Dive
Mon, 04/24/17 - 10:02 pm
Remicade
JNJ
biosimilars
Renflexis
Merck
Samsung Bioepis
10 Reasons Merck Could Be the World's Most Perfect Stock
Motley Fool
Fri, 04/21/17 - 11:43 am
Merck
Keytruda
Zepatier
biosimilars
M&A
drug pricing
animal health
J&J's Remicade sees 'very little' biosim erosion, but payers are sticking it to Xarelto
Fierce Pharma
Tue, 04/18/17 - 09:03 pm
JNJ
Remicade
biosimilars
payers
Xarelto
Inflectra
4 Reasons Why Roche Will Have the Best Growth in Big Pharma... and 1 Reason Why It Won't
Motley Fool
Wed, 04/12/17 - 10:33 am
Roche
Tecentriq
Perjeta
HER-2 postive breast cancer
Ocrevus
MS
multiple sclerosis
diagnostics
generics
biosimilars
3 Big Biotech Stocks With Big-Time Catalysts
Motley Fool
Sun, 04/9/17 - 12:36 pm
Regeneron
Praluent
Amgen
biosimilars
Amjevita
Humira
ABP-215
Avastin
ABP-980
Herceptin
Celgene
ozanimod
New drugs could save the US billions of dollars — but there's something holding them back
Business Insider
Fri, 04/7/17 - 12:09 am
biosimilars
American-made biosimilars a differentiator in US market, Coherus
Biopharma Reporter
Fri, 03/17/17 - 09:23 am
biosimilars
Coherus Biosciences
Merck KGaA in talks to sell its biosimilars R&D ops as shakeout looms
Endpoints
Thu, 03/9/17 - 11:36 am
Merck KGaA
biosimilars
M&A
R&D
Amgen accuses would-be copycat Coherus of stealing its Neulasta secrets
Fierce Pharma
Tue, 03/7/17 - 11:52 am
Coherus Biosciences
Amgen
Neulasta
biosimilars
Pfizer and Celltrion Seek Biosimilar Interchangeability for Crohn’s Disease Drug
Xtalks
Mon, 02/27/17 - 10:02 pm
Pfizer
Celltrion
biosimilars
Crohn's Disease
Inflectra
Remicade
Pfizer, Celltrion pushing for interchangeability with Inflectra
BioPharma Dive
Thu, 02/23/17 - 09:11 am
Pfizer
Celltrion
Inflectra
JNJ
biosimilars
Remicade
In Amgen-Sandoz SCOTUS case, biosim makers lambaste ruling's 6-month exclusivity gift
Fierce Pharma
Wed, 02/22/17 - 09:44 am
Amgen
Sandoz
Supreme Court
biosimilars
Pfizer's New Biosimilar Is Off and Running
Motley Fool
Sat, 02/4/17 - 10:00 am
Pfizer
biosimilars
Remicade
JNJ
Inflectra
rheumatoid arthritis
Amgen Gets EU Nod for Humira Biosimilar
Investopedia
Mon, 01/30/17 - 10:54 pm
Amgen
Humira
biosimilars
ABP 501
New competition took a bite out of J&J’s drug sales, but don’t expect the trend to dominate this earnings season
Marketwatch
Sun, 01/29/17 - 11:57 am
JNJ
earnings
Remicade
biosimilars
Novartis silently yanks a troubled biosimilar application; Chinese antibody developer draws $39M round
Endpoints
Sun, 01/29/17 - 11:53 am
Novartis
biosimilars
Zioxtenzo
Europe
Amgen
Neulasta
China
Pages
« first
‹ previous
…
20
21
22
23
24
25
26
27
28
…
next ›
last »